CONNECT WITH US
HealthTech

HealthTech

Viagra's cousin could help muscle cells stay primed for regeneration

Medical Xpress logo

Published on

Add as a preferred source on Google
Viagra's cousin could help muscle cells stay primed for regeneration

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

Tadalafil is a prescription drug closely related to Viagra. It is used to treat erectile dysfunction (ED) and the urinary symptoms of an enlarged prostate. Both competitive and recreational athletes sometimes use it too, to treat pulmonary arterial hypertension (PAH), a condition that can limit how well the body tolerates exercise.

It belongs to a class of drugs called phosphodiesterase type 5 (PDE5) inhibitors, which block an enzyme that breaks down a chemical messenger inside cells called cGMP, helping improve blood flow. cGMP does more than regulate blood vessels; it helps activate muscle stem cells involved in repairing damaged tissue.

In a recent study published in Molecular Biology Reports, researchers wanted to see if giving tadalafil directly to muscle cells over an extended period could help them multiply faster, survive stress and remain in a prime state to repair muscle damage.

The researchers grew muscle cells in petri dishes and ran a series of controlled experiments to observe how long-term exposure to 1 µM tadalafil for up to seven days alters cell growth, survival and genetic activity.

Tadalafil-treated cultures had more living mouse muscle precursor cells and fewer dead cells than untreated cultures. Even after seven days, fewer muscle cells in the drug group merged together to form mature muscle fibers. Rather than triggering immediate muscle-fiber growth, tadalafil fueled the expansion of precursor cells while holding back their maturation.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.